Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery

Circulation

Volumn 125, Issue 6, 2012, Pages 749-756

  Lopes, Renato D ^a,c   Mehta, Rajendra H ^a,c   Hafley, Gail E ^a   Williams, Judson B ^a   MacK, Michael J ^d   Peterson, Eric D ^a,c   Allen, Keith B ^e   Harrington, Robert A ^a,b   Gibson, C Michael ^f   Califf, Robert M ^b   Kouchoukos, Nicholas T ^g   Ferguson Jr , T Bruce ^a,c,h   Alexander, John H ^a,c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Cardiopulmonary Research Science and Technology Institute   (United States)

^e SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^f PERFUSE Angiographic Laboratory   (United States)

^g MISSOURI BAPTIST MEDICAL CENTER   (United States)

^h East Carolina Heart Institute   (United States)

Author keywords

Angiography; Coronary artery bypass; Graft survival; Outcome assessment; Veins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EDIFOLIGIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EX VIVO STUDY; FEMALE; GRAFT FAILURE; HAZARD RATIO; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; VEIN GRAFT FAILURE;

AGED; CLINICAL TRIALS, PHASE III AS TOPIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84862789799     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.040311     Document Type: Article

References (27)

1. Allen K, Cheng D, Cohn W, Conolly M, Edgerton J, Falk V, Martin J, Ohtsuka T, Vitali R. Endoscopic vascular harvest in coronary artery bypass grafting surgery: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS). Innovations (Phila). 2005; 1: 51-60.
2. Ferguson TB Jr., Peterson ED, Coombs LP, Eiken MC, Carey ML, Grover FL, DeLong ER. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. JAMA. 2003; 290: 49-56. (Pubitemid 37432865)
3. Holman WL, Sansom M, Kiefe CI, Peterson ED, Hubbard SG, Delong JF, Allman RM. Alabama Coronary Artery Bypass Grafting Project: results from phase II of a statewide quality improvement initiative. Ann Surg. 2004; 239: 99-109. (Pubitemid 38176379)
4. Bjork VO, Ekestrom S, Henze A, Ivert T, Landou C. Early and late patency of aortocoronary vein grafts. Scand J Thorac Cardiovasc Surg. 1981; 15: 11-21. (Pubitemid 11154161)
5. Roth JA, Cukingnan RA, Brown BG, Gocka E, Carey JS. Factors influencing patency of saphenous vein grafts. Ann Thorac Surg. 1979; 28: 176-183. (Pubitemid 10176374)
6. Cataldo G, Braga M, Pirotta N, Lavezzari M, Rovelli F, Marubini E. Factors influencing 1-year patency of coronary artery saphenous vein grafts: Studio Indobufene nel Bypass Aortocoronarico (SINBA). Circulation. 1993; 88(suppl): II-93-II-98.
7. Paz MA, Lupon J, Bosch X, Pomar JL, Sanz G. Predictors of early saphenous vein aortocoronary bypass graft occlusion: the GESIC Study Group. Ann Thorac Surg. 1993; 56: 1101-1106. (Pubitemid 23337599)
8. Cho KR, Kim JS, Choi JS, Kim KB. Serial angiographic follow-up of grafts one year and five years after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2006; 29: 511-516.
9. Kim KB, Cho KR, Jeong DS. Midterm angiographic follow-up after off-pump coronary artery bypass: serial comparison using early, 1-year, and 5-year postoperative angiograms. J Thorac Cardiovasc Surg. 2008; 135: 300-307.
10. O'Connor NJ, Morton JR, Birkmeyer JD, Olmstead EM, O'Connor GT. Effect of coronary artery diameter in patients undergoing coronary bypass surgery: Northern New England Cardiovascular Disease Study Group. Circulation. 1996; 93: 652-655. (Pubitemid 26052448)
11. Shah PJ, Gordon I, Fuller J, Seevanayagam S, Rosalion A, Tatoulis J, Raman JS, Buxton BF. Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg. 2003; 126: 1972-1977. (Pubitemid 38020761)
12. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr., Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchoukos NT. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005; 294: 2446-2454. (Pubitemid 41627922)
13. Alexander JH, Ferguson TB Jr., Joseph DM, Mack MJ, Wolf RK, Gibson CM, Gennevois D, Lorenz TJ, Harrington RA, Peterson ED, Lee KL, Califf RM, Kouchoukos NT. The PRoject of Ex-vivo Vein graft Engineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J. 2005; 150: 643-649. (Pubitemid 41396491)
14. European Association for Percutaneous Cardiovascular Interventions. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010; 31: 2501-2555.
15. Tonino PA, Fearon WF, DeBruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, MacCarthy PA, Van't Veer M, Pijls NH. Angiographic versus functional severity of coronary artery stenoses in the FAME study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation. J Am Coll Cardiol. 2010; 55: 2816-2821.
16. Lytle BW, Loop FD, Taylor PC, Simpfendorfer C, Kramer JR, Ratliff NB, Goormastic M, Cosgrove DM. Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1992; 103: 831-840.
17. Lytle BW, Loop FD, Taylor PC, Goormastic M, Stewart RW, Novoa R, McCarthy P, Cosgrove DM. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1993; 105: 605-614. (Pubitemid 23127718)
18. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996; 28: 616-626. (Pubitemid 26288642)
19. Halabi AR, Alexander JH, Shaw LK, Lorenz TJ, Liao L, Kong DF, Milano CA, Harrington RA, Smith PK. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol. 2005; 96: 1254-1259. (Pubitemid 41505404)
20. Lorenz RL, Schacky CV, Weber M, Meister W, Kotzur J, Reichardt B, Theisen K, Weber PC. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formation. Lancet. 1984; 1: 1261-1264. (Pubitemid 14111081)
21. Goldman S, Copeland J, Mortiz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S. Long-term graft patency (3 years) after coronary artery surgery: effects of aspirin: results of a VA Cooperative Study. Circulation. 1994; 89: 1138-1143.
22. Collaborative overview of randomised trials of antiplatelet therapy, II: maintenance of vascular graft of arterial patency by antiplatelet therapy. BMJ. 1994; 308: 159-168.
23. Tricoci P, Roe MT, Mulgund J, Newby LK, Smith SC Jr., Pollack CV Jr., Fintel DJ, Cannon CP, Bhatt DL, Gibler WB, Ohman EM, Peterson ED, Harrington RA. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. Arch Intern Med. 2006; 166: 806-811.
24. Gurbuz AT, Zia AA, Vuran AC, Cui H, Aytac A. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg. 2006; 29: 190-195. (Pubitemid 43120401)
25. Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery: a single-center, randomized, controlled trial. J Am Coll Cardiol. 2010; 56: 1639-1643.
26. A randomised, blinded, trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). Lancet. 1996; 348: 1329-1339.
27. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001; 345: 494-502. (Pubitemid 32758501)